Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CWBR - CohBar advances early-stage study for CB4211 in NASH and obesity patients

CWBR - CohBar advances early-stage study for CB4211 in NASH and obesity patients

August, 24 2020 11:24 AM CohBar Inc.

Dosing is underway for CohBar's (CWBR +1.4%) lead program, CB4211 in Phase 1b part of its Phase 1a/1b trial for nonalcoholic steatohepatitis (NASH) and obesity.
More news on: CohBar, Inc., Healthcare stocks news,

Stock Information

Company Name:	CohBar Inc.
Stock Symbol:	CWBR
Market:	OTC
Website:	cohbar.com

CWBR CWBR Quote CWBR Short CWBR News CWBR Articles CWBR Message Board

Get CWBR Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.